194861-70-6 Usage
General Description
Ginsenoside Rs3 is a phytochemical compound found in the root of the ginseng plant, Panax ginseng. It belongs to a class of compounds known as ginsenosides, which are known for their potential health benefits. Ginsenoside Rs3 has been studied for its potential anti-inflammatory, antioxidant, and immune-modulating properties. It has also shown promise in improving cognitive function, reducing stress, and enhancing physical endurance. Additionally, research suggests that ginsenoside Rs3 may have potential in the treatment of conditions such as diabetes, cardiovascular disease, and cancer. Overall, ginsenoside Rs3 is a compound with significant therapeutic potential and is the subject of ongoing research for its medicinal properties.
Check Digit Verification of cas no
The CAS Registry Mumber 194861-70-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,8,6 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 194861-70:
(8*1)+(7*9)+(6*4)+(5*8)+(4*6)+(3*1)+(2*7)+(1*0)=176
176 % 10 = 6
So 194861-70-6 is a valid CAS Registry Number.
InChI:InChI=1/C44H74O14/c1-22(2)11-10-15-43(8,53)25-12-16-41(6)24-13-18-44(9)40(4,5)30(14-17-42(44,7)26(24)19-27(47)31(25)41)57-39-37(35(51)32(48)28(20-45)55-39)58-38-36(52)34(50)33(49)29(56-38)21-54-23(3)46/h11,24-39,45,47-53H,10,12-21H2,1-9H3/t24?,25?,26?,27-,28+,29+,30?,31?,32+,33+,34-,35-,36+,37+,38-,39-,41+,42+,43-,44-/m0/s1
194861-70-6Relevant articles and documents
Regioselective acylation of ginsenosides by Novozyme 435 to generate molecular diversity
Teng, Rongwei,Ang, Chingseng,McManus, David,Armstrong, David,Mau, Shaiolim,Bacic, Antony
, p. 1860 - 1872 (2004)
Ginsenosides are major bioactive constituents of ginseng (Panax spp.; Araliaceae), a traditional Chinese medicinal herb. In order to increase the molecular diversity and broaden the potential usage of ginsenosides, ginsenosides Rd (1), Rg3 (2), (20R)-Rg3 (3), Rh2 (4), Re (5), Rh1 (8), Rg2 (9), gypenoside XVII (6), and pseudoginsenoside F11 (7) were regioselectively acylated with vinyl acetate, catalyzed by Novozyme 435 (lipase B from Candida antarctica), in organic solvents to afford different mono-acetyl ginsenosides. Ginsenoside Rd (1) was also acylated with vinyl decanoate or vinyl cinnamate to generate 1b and 1c, respectively. Acylation of glucosylated ginsenosides (1-4, 6, 8) occurred at the primary 6-OH function of the terminal glucose (Glc) moiety of the sugar at C(3) or C(20) of the dammarane-type aglycone. In contrast, ginsenosides 5, 7, and 9, containing mixed sugar moieties, resulted in acylation of both the rhamnose (Rha) and the glucose (Glc) moieties. In the case of ginsenoside Re (5) and pseudoginsenoside F11 (7), acylation at the secondary 4-OH function of the terminal Rha moiety, attached at C(3) of the aglycone, is preferred. The structures of all acylated products were determined by extensive MALDI-TOF-MS and NMR analyses.
